reboxetine has been researched along with tapentadol in 1 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (tapentadol) | Trials (tapentadol) | Recent Studies (post-2010) (tapentadol) |
---|---|---|---|---|---|
626 | 193 | 184 | 405 | 87 | 331 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CurrĂ², D; Greco, MC; Lisi, L; Navarra, P; Tringali, G | 1 |
1 other study(ies) available for reboxetine and tapentadol
Article | Year |
---|---|
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro.
Topics: Animals; Brain Stem; Calcitonin Gene-Related Peptide; Capsaicin; Male; Morphine; Morpholines; Phenols; Potassium; Rats; Rats, Wistar; Reboxetine; Tapentadol | 2014 |